De novo and pre-existing atrial fibrillation in acute coronary syndromes: impact on prognosis and cardiovascular events in long-term follow-up.
Piotr BuchtaZbigniew KalarusKatarzyna Mizia-StecKrzysztof MyrdaMichał SkrzypekMariusz Ga SiorPublished in: European heart journal. Acute cardiovascular care (2021)
De novo AF accounts for 40% of all AF cases in ACS patients and is an unfavourable in-hospital prognostic factor. The occurrence of de novo AF during ACS should require special attention and caution in the treatment of these patients.
Keyphrases
- prognostic factors
- atrial fibrillation
- acute coronary syndrome
- end stage renal disease
- cardiovascular events
- newly diagnosed
- chronic kidney disease
- ejection fraction
- healthcare
- type diabetes
- risk assessment
- percutaneous coronary intervention
- working memory
- venous thromboembolism
- left ventricular
- left atrial appendage
- smoking cessation
- adverse drug